Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
enzalutamide
×
Clear all
Filters
3
NCT04934722
2025-10-01
KEYNOTE-991
Merck Sharp & Dohme LLC
Phase 3
Completed
186 enrolled
14 charts
NCT03834519
2025-05-18
KEYLYNK-010
Merck Sharp & Dohme LLC
Phase 3
Completed
793 enrolled
23 charts